SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-045643
Filing Date
2021-07-06
Accepted
2021-07-06 18:51:14
Documents
1
Period of Report
2021-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12435
  Complete submission text file 0001209191-21-045643.txt   13878
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 18 NUTCRACKER LANE ALISO VIEJO CA 92656
Business Address
Drazba Brian G. (Reporting) CIK: 0001507369 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50484 | Film No.: 211075679